Literature DB >> 34901337

Imaging data reveal divergent longitudinal trajectories in PLS, ALS and poliomyelitis survivors: Group-level and single-subject traits.

Marlene Tahedl1,2, Stacey Li Hi Shing1, Eoin Finegan1, Rangariroyashe H Chipika1, Jasmin Lope1, Aizuri Murad1, Orla Hardiman1, Peter Bede1,3.   

Abstract

Imaging profiles from a longitudinal single-centre motor neuron disease study are presented. A standardized T1-weighted MRI protocol was implemented to characterise cortical disease burden trajectories across the UMN (upper motor neuron) - LMN (lower motor neuron) spectrum of motor neuron diseases (MNDs) (Tahedl et al., 2021). Patients with amyotrophic lateral sclerosis (ALS n = 61), patients with primary lateral sclerosis (PLS n = 23) and poliomyelitis survivors (PMS n = 45) were included. Up to four longitudinal scans were available for each patient, separated by an inter-scan-interval of four months. Individual and group-level cortical thickness profiles were appraised using a normalisation procedure with reference to subject-specific control groups. A z-scoring approach was utilised, where each patients' cortex was first segmented into 1000 cortical regions, and then rated as 'thin', 'thick', or 'comparable' to the corresponding region of a demographically-matched control cohort. Fractions of significantly 'thin' and 'thick' patches were calculated across the entire cerebral vertex as well as in specific brain regions, such as the motor cortex, parietal, frontal and temporal cortices. This approach allows the characterisation of disease burden in individual subjects as well as at a group-level, both cross-sectionally and longitudinally. The presented framework may aid the interpretation of individual cortical disease burden in other patient cohorts.
© 2021 The Author(s). Published by Elsevier Inc.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Clinical trials; Motor neuron disease; Neuroimaging; Poliomyelitis; Primary lateral sclerosis

Year:  2021        PMID: 34901337      PMCID: PMC8640870          DOI: 10.1016/j.dib.2021.107484

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the Data Cortical thickness values permit the interpretation of individual cortical thinning profiles in other neurological conditions. Regional ‘thin-patch’ fractions allow the characterisation of atrophy patterns in other conditions across the spectrum of motor neuron diseases. The presented statistical framework and methodological description may aid individualised data interpretation in other neurodegenerative conditions. Data may be incorporated in meta-analyses to probe the generalizability of our findings. Control data offer reference values for the interpretation of ‘external’ patient data.

Data Description

Anatomical patterns of cortical disease burden were evaluated in three patient cohorts across the spectrum of motor neuron diseases (MNDs): 61 patients with amyotrophic lateral sclerosis (‘ALS’: 43 males, age: 60.20+/– 9.62), 23 patients with primary lateral sclerosis (‘PLS’: 12 males, age: 58.52 ± 9.79), and 45 poliomyelitis-survivors (‘PMS’: 20 males, age: 66.07 ± 6.52). To characterise anatomical progression patterns, longitudinal data were also analysed. Cortical thickness values for up to four scans are presented per patient using a uniform inter-scan interval of four months. In Fig. 1, the availability of baseline and follow-up scans is presented in each clinical cohort (Fig. 1). Cross-sectional patient data were first contrasted to pooled normative data set of healthy controls (‘HC’, n = 776, 383 males, age: 55.08 ± 17.63) from Trinity College Dublin (n = 125) and subjects from the Cambridge Centre for Ageing and Neuroscience (Cam-CAN) database (n = 651) [2]. The cortical thickness profile of the healthy controls scanned at our institution is presented in the accompanying data sets. As described in the companion article [1], the fraction of significantly ‘thin’ and ‘thick’ patches was calculated in each patient by comparing individual cortical thickness maps to an age- and sex-matched control group. The flowchart for retrieving these metrics is presented in Fig. 2 which provides a step-by-step illustration of the methodological framework (Fig. 2). Our approach not only enabled the characterisation of disease burden in individual patients, but provided descriptive statistics for each patient group at each timepoint. As illustrated in Figs. 3–5, the colour coding indicates the percentage of patients in each group at each timepoint exhibiting statistically ‘thin’ or ‘thick’ patches in specific cortical regions (Fig. 3, Fig. 4, Fig. 5). Finally, the regional distribution of ‘thin’ and ‘thick’ patch load was also evaluated in each cortical region; in the motor, parietal, frontal, and temporal cortices. Cortical thin-patch burden in specific cerebral regions is presented as the radar charts (Fig. 6) across the three diagnostic groups (Fig. 6). The raw data which was utilised to calculate this distribution is available online at https://data.mendeley.com/datasets/3pnp4hkhnw/1. In the companion article, we also present ‘standard’ cortical thickness analyses, where the cortical thickness profile of the patient groups are contrasted to healthy controls, correcting for age and gender [1].
Fig. 1

Flow diagram indicating the number of patients in each study group at each timepoint.

Fig. 2

Flow chart illustrating the methodological framework for calculating ‘thin’ and ‘thick’ patch load. Please see text for specific details (section experimental design, materials and methods).

Fig. 3

The statistical brain maps of patients with amyotrophic lateral sclerosis (ALS) depicting the percentage of subjects exhibiting cortical thinning/hypertrophy in each cortical region, at each timepoint. Cool colours indicate cortical atrophy, hot colours refer to thick patches with respect to controls.

Fig. 5

The statistical brain maps of poliomyelitis survivors depicting the percentage of subjects exhibiting cortical thinning/hypertrophy in each cortical region, at each timepoint. Cool colours indicate cortical atrophy, hot colours refer to thick patches with respect to controls.

Fig. 4

The statistical brain maps of patients with primary lateral sclerosis (PLS) depicting the percentage of subjects exhibiting cortical thinning/hypertrophy in each cortical region, at each timepoint. Cool colours indicate cortical atrophy, hot colours refer to thick patches with respect to controls.

Fig. 6

Radar charts illustrating the topographical distribution of cortical disease burden in the different patient groups at baseline comparisons. Thin (A) and thick (B) patch fractions are presented for the entire brain and the motor, parietal, frontal and temporal cortices.

Flow diagram indicating the number of patients in each study group at each timepoint. Flow chart illustrating the methodological framework for calculating ‘thin’ and ‘thick’ patch load. Please see text for specific details (section experimental design, materials and methods). The statistical brain maps of patients with amyotrophic lateral sclerosis (ALS) depicting the percentage of subjects exhibiting cortical thinning/hypertrophy in each cortical region, at each timepoint. Cool colours indicate cortical atrophy, hot colours refer to thick patches with respect to controls. The statistical brain maps of patients with primary lateral sclerosis (PLS) depicting the percentage of subjects exhibiting cortical thinning/hypertrophy in each cortical region, at each timepoint. Cool colours indicate cortical atrophy, hot colours refer to thick patches with respect to controls. The statistical brain maps of poliomyelitis survivors depicting the percentage of subjects exhibiting cortical thinning/hypertrophy in each cortical region, at each timepoint. Cool colours indicate cortical atrophy, hot colours refer to thick patches with respect to controls.

Experimental Design, Materials and Methods

Motor neuron diseases encompass a range of clinically heterogeneous conditions, with considerable differences in clinical [3,4], radiological [5], [6], [7] and biomarker profiles [8], [9], [10]. While the radiological features of amyotrophic lateral sclerosis are well established [11,12], distinguishing imaging patterns in upper motor neuron predominant MNDs [13], [14], [15] and lower motor neuron predominant MNDs [16], [17], [18] are less well characterised. Machine-learning applications are increasingly utilised to interpret single MRI scans in motor neuron diseases [19], but the radiological distinction between ALS and PLS remains challenging [20], [21], [22] without the evaluation of spinal cord metrics [23,24]. Accordingly, in this study T1-weighted MRI data from 129 patients were included spanning the UMN-LMN spectrum of motor neuron diseases: 61 patients with amyotrophic lateral sclerosis (ALS), 23 patients with primary lateral sclerosis (PLS) and 45 poliomyelitis survivors (PMS). Data from multiple timepoints were available for each patient, acquired 4 months apart (Fig. 1). The research has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) and all patients provided informed consent in accordance with the ethics approval of the study (Medical Research Committee of Beaumont Hospital, Dublin, Ireland). ALS patients had ‘probable’ or ‘definite’ ALS according to the El Escorial criteria [25] and PLS patients were diagnosed based on the Gordon criteria [26]. A large, pooled control dataset (n = 776) was utilised to interpret patient data. The total number and fraction of significantly ‘thin’ and ‘thick’ patches were calculated as follows (Fig. 2): First, surface-based cortical thickness maps were obtained using FreeSurfer's recon-all pipeline on individual T1-weigthed MRI data, which were then converted into the Connectivity Informatics Technology Initiative (CIFTI) file format using the CIFTIFY toolbox [27] for visualization. Subsequently, the cortex was segmented into 1000 equally-sized region, and cortical thickness was averaged in a cortical ‘patch’. These maps were then converted into z-maps, with respect to an age- and sex- matched control group, encompassing sex-matched healthy controls with an age range of +/– 2 years of the individual patient. Finally, p-values were obtained from the z-scores using a Monte-Carlo permutation procedure, which is describe in more details in the companion article [1]. As both p-values representing the probability of higher and lower cortical thickness were calculated (representing focal atrophy or hypertrophy) p-maps were thresholded at a = 0.05/2 = 0.025. The number of whole-brain ‘thin’/’thick’ patches was then converted to fractions by dividing by the total number of patches. To characterise the regional profile of phenotype-associated atrophy, this procedure was repeated restricted to ‘patches’ within the (1) motor, (2) parietal, (3) frontal and (4) temporal cortices using the Desikan-Kiliany atlas [28] to define these anatomical regions. Radar charts illustrating the topographical distribution of cortical disease burden in the different patient groups at baseline comparisons. Thin (A) and thick (B) patch fractions are presented for the entire brain and the motor, parietal, frontal and temporal cortices.

Ethics Statement

This study was approved by the Medical Research Committee of Beaumont Hospital, Dublin, Ireland. All participants provided informed consent prior to participation.

CRediT authorship contribution statement

Marlene Tahedl: Conceptualization, Methodology, Formal analysis, Writing – original draft. Stacey Li Hi Shing: Investigation, Writing – review & editing. Eoin Finegan: Investigation, Writing – review & editing. Rangariroyashe H. Chipika: Investigation, Writing – review & editing. Jasmin Lope: Formal analysis, Investigation, Writing – review & editing. Aizuri Murad: Formal analysis, Investigation, Writing – review & editing. Orla Hardiman: Investigation, Writing – review & editing. Peter Bede: Conceptualization, Methodology, Formal analysis, Writing – original draft.

Declaration of Competing Interest

The authors have no competing financial interests or personal relationships to declare which may be construed as conflict of interest.
SubjectClinical neurology
Specific subject areaMagnetic resonance imaging, Quantitative neuroimaging, Cortical thickness, Motor neuron disease, Amyotrophic Lateral Sclerosis
Type of dataHigh-resolution T1-weighted magnetic resonance imaging (MRI) data acquired using a standardized acquisition protocol was used to calculate measures of cortical disease burden.
How data were acquiredMagnetic resonance imaging: quantitative neuroimaging metrics retrieved form a standardised acquisition protocol on a 3 Tesla Philips Achieva system using an 8-channel head coil (Philips Medical Systems, Best, The Netherlands)
Data formatCortical thickness measures are provided as raw values (in millimetres); thin/thick patch counts are given as fractions (indicating, per subject, how many of all patches spanning the distinct cortices were affected)
Parameters for data collectionLocal acquisition protocol for patients and healthy controls: 3D T1-weighted sequence: spatial resolution: 1 × 1 × 1 mm, Field of view: 256 × 256 × 160 mm, repetition time (TR) = 8.5 ms, echo time (TE) = 3.9 ms, Inversion time (TI) = 1060 ms, flip angle (FA) = 8°, SENSE factor = 1.5Cam-CAN database parameters: spatial resolution 1 × 1 × 1 mm, FOV = 256 × 240 × 192 mm, TR/TE 2.25/2.99 ms, TI 900 ms, FA 9°, GRAPPA factor 2.
Description of data collectionData were collected on a 3 Tesla MRI system. Demographic variables were recorded before the MRI scan, and a standardised neurological examination was also performed on the day of the MRI.
Data source locationInstitution: Computational neuroimaging group, Trinity Biomedical Sciences Institute, Trinity College DublinCity/Town/Region: DublinCountry: Ireland
Data accessibilityRaw cortical thickness and thin/thick patch fractions per subject and session data are available online at Mendeley Data; https://data.mendeley.com/datasets/3pnp4hkhnw/1
Related research articleTahedl M, Li Hi Shing S, Finegan E, Chipika RH, Lope J, Hardiman O, Bede P. Propagation patterns in motor neuron diseases: individual and phenotype-associated disease-burden trajectories across the UMN-LMN spectrum of MNDs. Neurobiol Aging. 2021 In Press
  28 in total

1.  Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study.

Authors:  Giorgia Querin; Peter Bede; Mohamed Mounir El Mendili; Menghan Li; Mélanie Pélégrini-Issac; Daisy Rinaldi; Martin Catala; Dario Saracino; François Salachas; Agnes Camuzat; Véronique Marchand-Pauvert; Julien Cohen-Adad; Olivier Colliot; Isabelle Le Ber; Pierre-François Pradat
Journal:  Ann Neurol       Date:  2019-06-27       Impact factor: 10.422

2.  Revisiting the spectrum of lower motor neuron diseases with snake eyes appearance on magnetic resonance imaging.

Authors:  M-V Lebouteux; J Franques; R Guillevin; E Delmont; T Lenglet; P Bede; C Desnuelle; J Pouget; H Pascal-Mousselard; P-F Pradat
Journal:  Eur J Neurol       Date:  2014-05-22       Impact factor: 6.089

3.  Multimodal spinal cord MRI offers accurate diagnostic classification in ALS.

Authors:  Giorgia Querin; Mohamed-Mounir El Mendili; Peter Bede; Sébastien Delphine; Timothée Lenglet; Véronique Marchand-Pauvert; Pierre-François Pradat
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-20       Impact factor: 10.154

4.  Ciftify: A framework for surface-based analysis of legacy MR acquisitions.

Authors:  Erin W Dickie; Alan Anticevic; Dawn E Smith; Timothy S Coalson; Mathuvanthi Manogaran; Navona Calarco; Joseph D Viviano; Matthew F Glasser; David C Van Essen; Aristotle N Voineskos
Journal:  Neuroimage       Date:  2019-05-12       Impact factor: 6.556

5.  The natural history of primary lateral sclerosis.

Authors:  P H Gordon; B Cheng; I B Katz; M Pinto; A P Hays; H Mitsumoto; L P Rowland
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

6.  Hippocampal pathology in amyotrophic lateral sclerosis: selective vulnerability of subfields and their associated projections.

Authors:  Foteini Christidi; Efstratios Karavasilis; Michail Rentzos; Georgios Velonakis; Vasiliki Zouvelou; Sofia Xirou; Georgios Argyropoulos; Ioannis Papatriantafyllou; Varvara Pantolewn; Panagiotis Ferentinos; Nikolaos Kelekis; Ioannis Seimenis; Ioannis Evdokimidis; Peter Bede
Journal:  Neurobiol Aging       Date:  2019-09-23       Impact factor: 4.673

7.  "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis.

Authors:  Rangariroyashe H Chipika; Eoin Finegan; Stacey Li Hi Shing; Mary Clare McKenna; Foteini Christidi; Kai Ming Chang; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Niall Pender; Siobhan Hutchinson; Colette Donaghy; Russell L McLaughlin; Orla Hardiman; Peter Bede
Journal:  Neuroimage Clin       Date:  2020-05-30       Impact factor: 4.881

Review 8.  Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis.

Authors:  Foteini Christidi; Efstratios Karavasilis; Michail Rentzos; Nikolaos Kelekis; Ioannis Evdokimidis; Peter Bede
Journal:  Front Neurol       Date:  2018-11-22       Impact factor: 4.003

9.  Patterned functional network disruption in amyotrophic lateral sclerosis.

Authors:  Stefan Dukic; Roisin McMackin; Teresa Buxo; Antonio Fasano; Rangariroyashe Chipika; Marta Pinto-Grau; Emmet Costello; Christina Schuster; Michaela Hammond; Mark Heverin; Amina Coffey; Michael Broderick; Parameswaran M Iyer; Kieran Mohr; Brighid Gavin; Niall Pender; Peter Bede; Muthuraman Muthuraman; Edmund C Lalor; Orla Hardiman; Bahman Nasseroleslami
Journal:  Hum Brain Mapp       Date:  2019-07-26       Impact factor: 5.038

10.  Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.

Authors:  Peter Bede; Rangariroyashe H Chipika; Eoin Finegan; Stacey Li Hi Shing; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Siobhan Hutchinson; Colette Donaghy; Russell L McLaughlin; Orla Hardiman
Journal:  Neuroimage Clin       Date:  2019-10-24       Impact factor: 4.881

View more
  1 in total

Review 1.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.